A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case

A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case–Control Study

Published:2018-12-03 Issue:3 Volume:17 Page:381-389
ISSN:1175-5652
Container-title:Applied Health Economics and Health Policy
language:en
Short-container-title:Appl Health Econ Health Policy

Author:

Touat Mehdi,Opatowski Marion,Brun-Buisson Christian,Cosker Kristel,Guillemot Didier,Salomon Jerome,Tuppin Philippe,de Lagasnerie Gregoire,Watier Laurence^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics and Econometrics,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40258-018-0451-1.pdf

Reference35 articles.

1. Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13:1057–98.

2. World Health Organization. WHO global strategy for containment of antimicrobial resistance. WHO/CDS/CSR/DRS/2001. 2. Geneva: The Organization; 2001. http://www.who.int/csr/resources/publications/drugresist/EGlobal_Strat.pdf .

3. Carmeli Y, Eliopoulos G, Mozaffari E, Samore M. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med. 2002;162:2223–8.

4. Cosgrove SE, Qi Y, Kaye KS, et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26:166–74.

5. Europäisches Zentrum für die Prävention und die Kontrolle von Krankheiten, editor. The bacterial challenge, time to react: a call to narrow the gap between multidrug-resistant bacteria in the EU and the development of new antibacterial agents. Stockholm: ECDC; 2009.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibacterial and Anti-Biofilm Efficacy of Endolysin LysAB1245 against a Panel of Important Pathogens;Pharmaceuticals;2024-01-25

2. Impact of septic episodes caused by Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa in a tertiary hospital: clinical and economic considerations in years 2018–2020;Journal of Infection and Public Health;2023-04

3. Évaluation socio-économique de la réduction d’usage des antibiotiques dans la filière porcine : le plan Ecoantibio 1;INRAE Productions Animales;2023-03-01

4. A 10-year microbiological study of Pseudomonas aeruginosa strains revealed the circulation of populations resistant to both carbapenems and quaternary ammonium compounds;Scientific Reports;2023-02-14

5. Economic burden of antimicrobial resistance and inappropriate empiric treatment in Thailand;Antimicrobial Stewardship & Healthcare Epidemiology;2023